|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.96 USD | -3.35% |
|
+15.01% | +19.40% |
| 03-24 | Markets Rally on Tariff Rumors |  |
| 03-24 | JPMorgan Upgrades Alnylam Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $328 From $280 | MT |
Quotes 5-day view: Alnylam Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 19/03/2025 | 20/03/2025 | 21/03/2025 | 24/03/2025 | 25/03/2025 | |
|---|---|---|---|---|---|
| Last | 253.44 $ | 253.54 $ | 283.34 $ | 290.70 $ | 280.96 $ |
| Volume | 987,481 | 799,079 | 3,150,362 | 1,768,154 | 1,065,502 |
| Change | +3.74% | +0.04% | +11.75% | +2.60% | -3.35% |
| Opening | 243.44 $ | 254.09 $ | 261.82 $ | 288.54 $ | 290.05 $ |
| High | 255.35 $ | 261.90 $ | 289.44 $ | 300.90 $ | 292.62 $ |
| Low | 243.44 $ | 252.38 $ | 261.00 $ | 287.77 $ | 280.33 $ |
Performance
| 1 day | -3.35% | ||
| 1 week | +15.01% | ||
| Current month | +13.86% | ||
| 1 month | +14.58% | ||
| 3 months | +15.50% | ||
| 6 months | +3.02% | ||
| Current year | +19.40% | ||
| 1 year | +84.76% | ||
| 3 years | +71.52% | ||
| 5 years | +184.43% | ||
| 10 years | +176.05% |
Volumes
marketsDaily volume
1,065,502
Estimated daily volume
1,065,502
Avg. Volume 20 sessions
875,446
Daily volume ratio
1.22
Avg. Volume 20 sessions USD
245,965,308.16
Record volume 1
18,362,420
Record volume 2
16,731,380
Record volume 3
9,611,536
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
36,372,282,549
Net sales (USD)
2,248,243,000
Number of employees
2,230
Sales / Employee (USD)
1,008,181
Free-Float
99.2 %
Free-Float capitalization (USD)
36,082,591,436
Average Daily Capital Traded
0.68%
Indicators
Moving average 5 days
272.4
Moving average 20 days
248.87
Moving average 50 days
257.65
Moving average 100 days
255.03
Price spread / (MMA5)
-3.05%
Price spread / (MMA20)
-11.42%
Price spread / (MMA50)
-8.30%
Price spread / (MMA100)
-9.23%
STIM
RSI 9 days
78.58
RSI 14 days
71.41
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.35% | +15.01% | +84.76% | +71.52% | 36.37B | ||
| -1.45% | +3.63% | +10.25% | +194.91% | 765B | ||
| -1.39% | -1.97% | +3.74% | -8.99% | 388B | ||
| -3.74% | -5.85% | +12.78% | +24.80% | 356B | ||
| -2.31% | -7.72% | -43.25% | +38.37% | 330B | ||
| -1.01% | -0.95% | +33.41% | -18.90% | 278B | ||
| -0.87% | -4.63% | +7.64% | +13.58% | 227B | ||
| -4.81% | -7.23% | -29.88% | +8.03% | 222B | ||
| -1.39% | -1.62% | +12.19% | +19.03% | 211B | ||
| -2.39% | -3.70% | +9.27% | +28.51% | 165B | ||
| Average | -1.17% | -1.30% | +10.09% | +37.09% | 297.79B | |
| Weighted average by Cap. | -0.75% | -1.82% | +3.75% | +59.78% |
Historical Quotes: Alnylam Pharmaceuticals, Inc.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
7ccef32b2f7d.K2r0WF32Ina4j7L8NWp-0mKYh0N3ThSnHpppsktDNno.YwSEOTW-QB7g5IO_UVxPtT3QzihOf1bfffMjxCMGXjdtL4UXEsZbNdnKhg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 20:00:00 | 280.89 | 374 | 647,773 |
| 20:00:00 | 280.96 | 190,657 | 647,399 |
| 19:59:59 | 280.87 | 3,047 | 456,742 |
| 19:59:59 | 280.87 | 250 | 453,695 |
| 19:59:59 | 280.92 | 100 | 453,445 |
| 19:59:58 | 280.72 | 100 | 453,345 |
| 19:59:58 | 280.73 | 100 | 453,245 |
| 19:59:58 | 280.72 | 100 | 453,145 |
| 19:59:58 | 280.84 | 104 | 453,045 |
| 19:59:58 | 280.91 | 100 | 452,941 |
Course Extremes
1 week
252.38
300.9
1 month
230.79
300.9
Current year
230.79
300.9
1 year
141.98
304.39
3 years
117.58
304.39
5 years
98.01
304.39
10 years
31.38
304.39
Monthly variations
Annual variations
| 2025 | +19.40% | ||
| 2024 | +22.94% | ||
| 2023 | -19.46% | ||
| 2022 | +40.14% | ||
| 2021 | +30.48% | ||
| 2020 | +12.85% | ||
| 2019 | +57.96% | ||
| 2018 | -42.61% | ||
| 2017 | +239.34% | ||
| 2016 | -60.23% | ||
| 2015 | -2.95% | ||
| 2014 | +50.86% | ||
| 2013 | +252.33% | ||
| 2012 | +123.93% | ||
| 2011 | -17.34% | ||
| 2010 | -44.04% | ||
| 2009 | -28.75% | ||
| 2008 | -14.96% | ||
| 2007 | +35.89% | ||
| 2006 | +60.18% | ||
| 2005 | +78.85% | ||
| 2004 | +24.29% |
- Stock Market
- Equities
- ALNY Stock
- Quotes Alnylam Pharmaceuticals, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition